Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 0 | 0 | 250 |
| Gross Profit | N/A | N/A | N/A | N/A | 250 |
| Operating Expenses | 29,055 | 24,346 | 23,488 | 23,695 | 30,710 |
| Operating Income | -29,055 | -24,346 | -23,488 | -23,695 | -30,460 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 149 | 92 | 98 | 765 | 80 |
| Pre-tax Income | -28,906 | -24,254 | -23,390 | -22,930 | -30,381 |
| Net Income Continuous | -28,906 | -24,254 | -23,390 | -22,930 | -30,381 |
| Net Income | $-28,906 | $-24,254 | $-23,390 | $-22,930 | $-30,381 |
| EPS Basic Total Ops | -38.50 | -32.50 | -31.00 | -34.00 | -45.00 |
| EPS Basic Continuous Ops | -38.62 | -32.49 | -31.30 | -33.81 | -45.10 |
| EPS Diluted Total Ops | -38.50 | -32.50 | -31.00 | -34.00 | -45.00 |
| EPS Diluted Continuous Ops | -38.62 | -32.49 | -31.30 | -33.81 | -45.10 |
| EBITDA(a) | $-28,767 | $-24,033 | $-23,174 | $-23,315 | $-30,133 |